The limited impact of CYP3A5 genotype for the pharmacokinetics of CYP3A substrates

被引：7

作者：

Burk, Oliver

Schwab, Matthias

机构：

[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany

[2] Univ Tubingen, Tubingen, Germany

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2007年 / 63卷 / 12期

关键词：

CYTOCHROME-P450; 3A; DRUG-METABOLISM; MIDAZOLAM; VARIABILITY; EXPRESSION;

D O I：

10.1007/s00228-007-0393-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1097 / 1098

页数：2

共 16 条

[1] Cytochrome P450 3A and their regulation [J].

Burk, O ;

Wojnowski, L .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 (01) :105-124

[2]

FROMM MF, 2007, EUR J CLIN PHARM

[3]

GORSKI JC, 1994, BIOCHEM PHARMACOL, V47, P1643

[4]

Haehner BD, 1996, MOL PHARMACOL, V50, P52

[5] Evidence of significant contribution from CYP3A5 to hepatic drug metabolism [J].

Huang, WL ;

Lin, YS ;

McConn, DJ ;

Calamia, JC ;

Totah, RA ;

Isoherranen, N ;

Glodowski, M ;

Thummel, KE .

DRUG METABOLISM AND DISPOSITION, 2004, 32 (12) :1434-1445

[6] The genetic determinants of the CYP3A5 polymorphism [J].

Hustert, E ;

Haberl, M ;

Burk, O ;

Wolbold, R ;

He, YQ ;

Klein, K ;

Nuessler, AC ;

Neuhaus, P ;

Klattig, J ;

Eiselt, R ;

Koch, I ;

Zibat, A ;

Brockmöller, J ;

Halpert, JR ;

Zanger, UM ;

Wojnowski, L .

PHARMACOGENETICS, 2001, 11 (09) :773-779

[7] Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression [J].

Kuehl, P ;

Zhang, J ;

Lin, Y ;

Lamba, J ;

Assem, M ;

Schuetz, J ;

Watkins, PB ;

Daly, A ;

Wrighton, SA ;

Hall, SD ;

Maurel, P ;

Relling, M ;

Brimer, C ;

Yasuda, K ;

Venkataramanan, R ;

Strom, S ;

Thummel, K ;

Boguski, MS ;

Schuetz, E .

NATURE GENETICS, 2001, 27 (04) :383-391

[8] In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration [J].

Lin, YS ;

Lockwood, GF ;

Graham, MA ;

Brian, WR ;

Loi, CM ;

Dobrinska, MR ;

Shen, DD ;

Watkins, PB ;

Wilkinson, GR ;

Kharasch, ED ;

Thummel, KE .

PHARMACOGENETICS, 2001, 11 (09) :781-791

[9] Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism [J].

Lin, YS ;

Dowling, ALS ;

Quigley, SD ;

Farin, FM ;

Zhang, J ;

Lamba, J ;

Schuetz, EG ;

Thummel, KE .

MOLECULAR PHARMACOLOGY, 2002, 62 (01) :162-172

[10] Evaluation of the genetic component of variability in CYP3A4 activity:: a repeated drug administration method [J].

Özdemir, V ;

Kalow, W ;

Tang, BK ;

Paterson, AD ;

Walker, SE ;

Endrenyi, L ;

Kashuba, ADM .

PHARMACOGENETICS, 2000, 10 (05) :373-388

← 1 2 →